Literature DB >> 27884233

Hypertension, Left Ventricular Hypertrophy, and Myocardial Ischemia.

Tony Stanton1, Francis G Dunn2.   

Abstract

The risks associated with hypertension emerge through a series of complex interactions. Myocardial ischemia is the major contributor to this risk. The mechanisms driving ischemia reflect many of the key factors in hypertension, including endothelial and neurohumoral factors, fibrosis, and hemodynamics. Left ventricular hypertrophy and fibrosis are of fundamental importance and together with hemodynamics provide an optimal template for myocardial ischemia. Understanding the pathophysiology has aided a more rational management approach but challenges remain which, if surmounted, will have an impact on the morbidity and mortality caused by myocardial ischemia in patients with hypertension. Copyright Â
© 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Hypertension; Ischemia; Management; Mechanisms; Perfusion

Mesh:

Substances:

Year:  2016        PMID: 27884233     DOI: 10.1016/j.mcna.2016.08.003

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  7 in total

1.  The lncRNA Plscr4 Controls Cardiac Hypertrophy by Regulating miR-214.

Authors:  Lifang Lv; Tianyu Li; Xuelian Li; Chaoqian Xu; Qiushuang Liu; Hua Jiang; Yingnan Li; Yingqi Liu; He Yan; Qihe Huang; Yuhong Zhou; Mingyu Zhang; Hongli Shan; Haihai Liang
Journal:  Mol Ther Nucleic Acids       Date:  2017-12-30       Impact factor: 8.886

2.  Danshenol A Alleviates Hypertension-Induced Cardiac Remodeling by Ameliorating Mitochondrial Dysfunction and Suppressing Reactive Oxygen Species Production.

Authors:  Kai Chen; Yiqing Guan; Yunci Ma; Dongling Quan; Jingru Zhang; Shaoyu Wu; Xin Liu; Lin Lv; Guohua Zhang
Journal:  Oxid Med Cell Longev       Date:  2019-09-11       Impact factor: 6.543

3.  Higher left ventricular mass-wall stress-heart rate product and outcome in aortic valve stenosis.

Authors:  Eva Gerdts; Sahrai Saeed; Helga Midtbø; Anne Rossebø; John Boyd Chambers; Eigir Einarsen; Edda Bahlmann; Richard Devereux
Journal:  Heart       Date:  2019-06-01       Impact factor: 5.994

4.  Mechanism of tanshinones and phenolic acids from Danshen in the treatment of coronary heart disease based on co-expression network.

Authors:  Dongxue Wu; Mengqi Huo; Xi Chen; Yanling Zhang; Yanjiang Qiao
Journal:  BMC Complement Med Ther       Date:  2020-02-03

5.  Expression Profiles of Circular RNA in Aortic Vascular Tissues of Spontaneously Hypertensive Rats.

Authors:  Ying Liu; Ying Dong; Zhaojie Dong; Jiawei Song; Zhenzhou Zhang; Lirong Liang; Xiaoyan Liu; Lanlan Sun; Xueting Li; Miwen Zhang; Yihang Chen; Ran Miao; Jiuchang Zhong
Journal:  Front Cardiovasc Med       Date:  2021-12-20

6.  LncRNA Gm43843 Promotes Cardiac Hypertrophy via miR-153-3p/Cacna1c Axis.

Authors:  Yuhua Cai; Yunpeng Li
Journal:  Evid Based Complement Alternat Med       Date:  2022-10-10       Impact factor: 2.650

7.  Cardiac adaptation to hypertension in adult female Dahl salt-sensitive rats is dependent on ovarian function, but loss of ovarian function does not predict early maladaptation.

Authors:  Stian Ludvigsen; Costantino Mancusi; Simon Kildal; Giovanni de Simone; Eva Gerdts; Kirsti Ytrehus
Journal:  Physiol Rep       Date:  2018-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.